Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.08%105.32M | 10.36%105.36M | 38.89%102.23M | 2.41%403M | 28.40%132.73M | -13.90%101.19M | 4.75%95.47M | -9.65%73.6M | 21.25%393.51M | 16.13%103.38M |
| Operating revenue | 4.08%105.32M | 10.36%105.36M | 38.89%102.23M | 2.41%403M | 28.40%132.73M | -13.90%101.19M | 4.75%95.47M | -9.65%73.6M | 21.25%393.51M | 16.13%103.38M |
| Cost of revenue | 1.25%55.15M | 16.37%57.58M | 53.23%57.91M | 0.08%219.23M | 29.58%77.48M | -14.00%54.47M | -4.39%49.48M | -14.43%37.79M | 18.76%219.05M | 17.69%59.8M |
| Gross profit | 7.39%50.17M | 3.91%47.79M | 23.76%44.32M | 5.34%183.77M | 26.78%55.25M | -13.77%46.72M | 16.76%45.99M | -4.00%35.81M | 24.53%174.45M | 14.06%43.58M |
| Operating expense | 8.51%34.84M | 5.00%34.17M | 13.61%33.06M | 7.36%128.98M | 11.55%35.23M | 0.89%32.1M | 12.68%32.54M | 4.48%29.1M | 24.58%120.14M | 18.84%31.59M |
| Selling and administrative expenses | 15.18%22.45M | 3.30%22.13M | 12.64%20.69M | 5.90%80.1M | 3.85%20.82M | 1.30%19.49M | 16.90%21.43M | 1.90%18.37M | 24.03%75.64M | 13.12%20.05M |
| -General and administrative expense | 15.18%22.45M | 3.30%22.13M | 12.64%20.69M | 5.90%80.1M | 3.85%20.82M | 1.30%19.49M | 16.90%21.43M | 1.90%18.37M | 24.03%75.64M | 13.12%20.05M |
| Depreciation amortization depletion | -1.79%12.39M | 8.28%12.04M | 15.27%12.37M | 10.90%48.99M | 29.55%14.54M | 0.25%12.62M | 5.33%11.12M | 9.21%10.73M | 25.59%44.18M | 30.69%11.22M |
| -Depreciation and amortization | -1.79%12.39M | 8.28%12.04M | 15.27%12.37M | 10.90%48.99M | 29.55%14.54M | 0.25%12.62M | 5.33%11.12M | 9.21%10.73M | 25.59%44.18M | 30.69%11.22M |
| Other operating expenses | ---- | ---- | ---- | -137.19%-119K | ---- | ---- | ---- | ---- | 17.22%320K | ---- |
| Operating profit | 4.92%15.34M | 1.25%13.62M | 67.77%11.26M | 0.89%54.79M | 66.93%20.02M | -34.63%14.62M | 27.97%13.45M | -28.98%6.71M | 24.41%54.31M | 3.14%11.99M |
| Net non-operating interest income (expenses) | 25.61%-3.23M | -4.43%-3.61M | 0.03%-3.78M | -12.02%-15.42M | -13.14%-3.84M | -17.05%-4.34M | 7.47%-3.46M | -29.20%-3.78M | -60.45%-13.76M | -5.41%-3.39M |
| Non-operating interest expense | -25.61%3.23M | 4.43%3.61M | -0.03%3.78M | 13.36%14.78M | 20.01%3.2M | 17.05%4.34M | -7.47%3.46M | 29.20%3.78M | 68.58%13.04M | 12.34%2.67M |
| Total other finance cost | ---- | ---- | ---- | -12.14%637K | ---- | ---- | ---- | ---- | -14.10%725K | ---- |
| Other net income (expenses) | 4.52M | 2.63M | -620K | -3K | -617K | |||||
| Special income (charges) | --4.52M | --2.63M | --0 | ---620K | ---3K | --0 | --0 | ---617K | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | --1.48M | --139K | --0 | ---- | ---- | --0 | --0 | --617K | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --620K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of property,plant,equipment | --6M | --2.77M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Income before tax | 61.76%16.63M | 26.48%12.64M | 223.49%7.48M | -4.42%38.76M | 88.11%16.17M | -44.90%10.28M | 47.52%9.99M | -64.56%2.31M | 0.77%40.55M | -36.63%8.6M |
| Income tax | 65.23%4.24M | 47.18%3.1M | 150.58%1.29M | 26.35%11.47M | 1,094.49%6.28M | -46.66%2.57M | 8.15%2.11M | -71.30%514K | -23.76%9.08M | -86.08%526K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 60.60%12.38M | 20.94%9.53M | 244.33%6.19M | -13.30%27.28M | 22.53%9.89M | -44.29%7.71M | 63.44%7.88M | -62.00%1.8M | 11.08%31.47M | -17.53%8.07M |
| Net income continuous operations | 60.60%12.38M | 20.94%9.53M | 244.33%6.19M | -13.30%27.28M | 22.53%9.89M | -44.29%7.71M | 63.44%7.88M | -62.00%1.8M | 11.08%31.47M | -17.53%8.07M |
| Noncontrolling interests | -50.00%173K | -10.50%341K | 7.83%358K | 46.71%1.63M | 116.79%568K | 24.46%346K | 50.00%381K | 5.40%332K | -42.95%1.11M | -40.05%262K |
| Net income attributable to the company | 65.80%12.21M | 22.53%9.19M | 297.89%5.83M | -15.50%25.65M | 19.37%9.32M | -45.70%7.37M | 64.19%7.5M | -66.81%1.47M | 15.06%30.36M | -16.48%7.81M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 65.80%12.21M | 22.53%9.19M | 297.89%5.83M | -15.50%25.65M | 19.37%9.32M | -45.70%7.37M | 64.19%7.5M | -66.81%1.47M | 15.06%30.36M | -16.48%7.81M |
| Diluted earnings per share | 58.33%0.19 | 25.00%0.15 | 400.00%0.1 | -16.00%0.42 | 23.08%0.16 | -45.45%0.12 | 50.00%0.12 | -71.43%0.02 | 11.11%0.5 | -18.75%0.13 |
| Basic earnings per share | 50.00%0.18 | 25.00%0.15 | 350.00%0.09 | -16.33%0.41 | 25.00%0.15 | -45.45%0.12 | 50.00%0.12 | -71.43%0.02 | 11.36%0.49 | -25.00%0.12 |
| Dividend per share | 16.67%0.035 | 16.67%0.035 | 16.67%0.035 | 38.89%0.125 | 16.67%0.035 | 50.00%0.03 | 50.00%0.03 | 50.00%0.03 | 38.46%0.09 | 50.00%0.03 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.